How Cannabis including CBG cannabinoides are useful for some form cancer, according to a study made by cannabics a leader of medicine on the CBD located in Israel.
** Video on cannabidiol and its anti-metastatic action in cancer treatment: **
Dr. Pierre-Yves Desprez (California Pacific Medical Center, San Francisco) presents the results of his studies on cannabidiol. This compound of cannabis offers encouraging perspectives in oncology due to its anti-metastatic action.
Video extracted from the Leflyer review channel.
Here is a summary of key information on the usefulness of CBD and cannabinoids such as CBG in the treatment of certain cancers, according to the studies mentioned:
Summary
- A preclinical study by Cannabics Pharmaceuticals, an Israeli company specializing in cannabinoid medicine, examined the in vitro anti-tumor effects of Cannabigerol (CBG) on human cancer cellular lines.
- The preliminary results show that the CBG has a greater anti-tumor effect on the cancer cells of the stomach and bones than the CBGA (acid form of the CBG).
- The CBG has proven to induce necrotic effects (destruction of cells) on these cancer cells, while the CBGA did not have such an effect.
- These results support the previous research of cannabics pharmaceuticals showing differential anti-tumor effects when using various cannabinoids on human cancer cells.
- These preliminary results could allow Cannabics Pharmaceuticals to offer more complete recommendations to patients on therapy protocols to cannabinoids to maximize positive results.
CBD, another non-psychoactive cannabinoid, has also shown promising anti-metastatic properties in other studies.
How the CBG (Cannabigerol) kill gastrointestinal cancer cells
Preclinical study on the anti-tumor effects of cannabigerol (CBG)
Cannabics Pharmaceuticals Inc., an Israeli company specializing in personalized cannabinoid medicine for cancer, published preliminary results of a preclinical study. The study examined the effect of CBG on human cancer cell lines in ** stomach and bones **.
Preliminary results:
- The CBG showed a **greater anti-tumor effect** that the CBGA (acid form of the CBG) on the cancer cells of the ** stomach and the bones.
- CBG A **induces cell death** (necrosis) in cancer cells, while the CBGA did not have this effect.
Implications:
- These results support the previous research of cannabics on the anti-tumor effects of cannabinoids.
- They could allow cannabics to offer ** personalized therapy protocols ** more complete to patients with cancer.
Dr. Yaakov Waksman, Director of research on cannabidiol at Cannabics said:
"The CBG arouses great interest due to its potential therapeutic properties."
"These preliminary results illustrate how purified cannabinoids can produce anti-tumor activity."
"Additional studies are necessary to confirm these results."
Additional information:
- The CBG is a non -psychoactive cannabinoid present in small quantities in the cannabis plant.
- It is known for its anti-inflammatory and antibacterial properties.
- CBGA is the acid form of the CBG.
- The entourage effect is the synergistic interaction between the different cannabinoids and other compounds present in the cannabis plant.
Other CBG and cancer studies
(https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7914500/)
(https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7914500/)
(https://pubmed.ncbi.nlm.nih.gov/33912679/)
Warning : The data on this page is purely informational and does not engage the responsibility of its author, the products sold on this site are food supplements and are not intended to cure, treat or diagnose, call on a health professional.
